Open Government Portal

Open Data Portal Catalogue Dataset
Found 5468 records

Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Loratadine Abnormal heart rhythm QT interval prolongation use of over-the-counter drug products

Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Levetiracetam Methotrexate assessing potential risk Drug-Drug Interaction

Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Lanoxin Toloxin Apo-digoxin PMS-digoxin Digoxin assessing potential higher risk risk of Death

Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review KEPPRA levetiracetam assessing potential risk Acute Kidney Injury Acute renal failure Interstitial nephritis

A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review INTUNIV XR guanfacine hydrochloride assessing potential risk Raynaud's Phenomenon disorder of the blood vessels fingers and toes enough blood-and-oxygen lack of blood-and-oxygen pale skin bluish colour skin ...

As part of Health Canada's ongoing monitoring of glistening development in IOLs, Health Canada reviewed the available safety information related …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Intraocular lenses assessing potential risk small pockets liquid in intraocular-lenses glistening

A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydroxyzine ATARAX assessing potential risk abnormal heart rhythm abnormal changes electrical-activity of the-heart QT interval prolongation

It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydrocodone-containing products assessing risk slow breathing Serious-Breathing-Problems respiratory depression

Health Canada reviewed the potential risk of liver injury with green tea extract-containing natural health products because of ongoing reports …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Green tea extract natural health products assessing potential risk liver injury hepatotoxicity

The safety of all vaccines, including Gardasil, is under continuous monitoring by Health Canada and the Public Health Agency of …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review GARDASIL all vaccines side-effects after vaccination Quadrivalent Human Papillomavirus Recombinant Vaccine assessing general safety Autoimmune Cardiovascular Diseases body's own-defence-system attacks-itself autoimmune diseases diseases affecting ...